Mathilde Bonnet

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Collaborators (7)

nathalie ROLHION

Guillaume Dalmasso

Université Clermont Auvergne

Romain Villéger

Maître de Conférences / Associate professor

University of Poitiers

Julien Delmas

Frédéric A. Carvalho

Université Clermont Auvergne

Mathias Chamaillard

Université de Lille

Nicolas Barnich

Université Clermont Auvergne

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mathilde Bonnet

Research Interests

Explore related searches

Contact this professor

Articles (15)

Collaborators (7)

nathalie ROLHION

Guillaume Dalmasso

Romain Villéger

Julien Delmas

Frédéric A. Carvalho

Mathias Chamaillard

Nicolas Barnich

Make your next move.

Mathilde Bonnet

Research Interests

Explore related searches

Contact this professor

Articles (15)

Vat-Mediated Mucus Penetration Enables Genotoxic Activity of pks+ Escherichia coli

L-serine promotes pro-carcinogenic effects of colibactin-producing <i>E. coli</i>

Pasteurized <i>Akkermansia muciniphila</i> improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice

The colibactin-producing <i>Escherichia coli</i> alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance

Increased levels of anti-Encephalitozoon intestinalis antibodies in patients with colorectal cancer.

Preclinical and clinical evidence of the association of colibactin-producing <i>Escherichia coli</i> with anxiety and depression in colon cancer.

Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing <i>Escherichia coli</i> in <i> Apc <sup>Min/+</sup> </i> mice

Probiotics/Synbiotics to Reduce Infectious Complications after Colorectal Surgery: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms.

Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing <i>Escherichia coli</i> in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE).

Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing <i>Escherichia coli</i> in Colorectal Cancer

Fecal dysbiosis associated with colonic hypersensitivity and behavioral alterations in chronically Blastocystis-infected rats.

Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer.

Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in ApcMin/+ Mice.

Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE).

Collaborators (7)

nathalie ROLHION

Guillaume Dalmasso

Romain Villéger

Julien Delmas

Frédéric A. Carvalho

Mathias Chamaillard

Nicolas Barnich

Make your next move.